Sean Wieland Stock Analyst Profile - Piper Sandler Research Coverage - Stocknear

Sean Wieland

Stock Analyst at Piper Sandler

(2.48)
# 3179
Out of 5,493 analysts
51
Total ratings
Success rate
Average return

17 Stocks

Name Action PT Current % Upside Ratings Updated
OMCL Omnicell
Maintains: Overweight
57 55
30.72 79.04% 11 Aug 11, 2025
PRVA Privia Health Gr
Maintains: Overweight
35 36
23.96 50.25% 3 Aug 11, 2025
AMWL American Well
Maintains: Overweight
100 120
6.19 1838.61% 2 Jun 23, 2022
HIMS Hims & Hers Health
Maintains: Overweight
8 6
58.37 -89.72% 3 May 26, 2022
DOCS Doximity
Maintains: Overweight
81 44
74.41 -40.87% 2 May 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
34 27
n/a n/a 2 Mar 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
37 20
n/a n/a 5 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
261 231
179.5 28.69% 4 Feb 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
68 80
n/a n/a 4 Jan 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
305 291
8.14 3474.94% 5 Feb 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
40 41
n/a n/a 2 Feb 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
55 143
n/a n/a 3 Oct 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
54
n/a n/a 1 Aug 31, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
45
n/a n/a 1 Jul 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25
n/a n/a 1 Jan 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 13, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Jan 13, 2016